A Study of Olanzapine After Intranasal and Intramuscular Administration

NCT06600477 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: olanzapine

Sponsor

Neurelis, Inc.